🇺🇸 FDA

Drug profile · INN

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran)

SPIKEVAX (PREVIOUSLY COVID-19 VACCINE MODERNA) (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL

Patents linked
0
News articles
0

Quick answer

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran) (SPIKEVAX (PREVIOUSLY COVID-19 VACCINE MODERNA) (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran)
Brand SPIKEVAX (PREVIOUSLY COVID-19 VACCINE MODERNA) (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL

Frequently asked questions

What is coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran)?

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran) (SPIKEVAX (PREVIOUSLY COVID-19 VACCINE MODERNA) (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran)?

SPIKEVAX (PREVIOUSLY COVID-19 VACCINE MODERNA) (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL is a marketed brand name for coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran). Check FDA Drugs@FDA for the current US label holder and prescribing information.